Bailard’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-4,017
Closed -$1.09M 770
2025
Q3
$1.09M Sell
4,017
-203
-5% -$55.2K 0.02% 321
2025
Q2
$1.16M Buy
4,220
+230
+6% +$62.5K 0.03% 304
2025
Q1
$1.06M Hold
3,990
0.03% 299
2024
Q4
$927K Buy
3,990
+488
+14% +$112K 0.02% 307
2024
Q3
$773K Buy
3,502
+5
+0.1% +$1.03K 0.02% 355
2024
Q2
$688K Sell
3,497
-72
-2% -$14.9K 0.02% 372
2024
Q1
$768K Sell
3,569
-1,422
-28% -$299K 0.02% 348
2023
Q4
$1.05M Hold
4,991
0.03% 290
2023
Q3
$999K Buy
+4,991
New +$992K 0.03% 270
2021
Q4
Sell
-1,152
Closed -$223K 731
2021
Q3
$223K Buy
1,152
+64
+6% +$13K 0.01% 639
2021
Q2
$231K Hold
1,088
0.01% 629
2021
Q1
$222K Buy
+1,088
New +$214K 0.01% 631
2019
Q1
Sell
-1,215
Closed -$229K 549
2018
Q4
$229K Buy
+1,215
New +$224K 0.02% 457

Other funds holding CME

Bailard's CME Position: Q4 2025 in Review

Bailard sold out of CME Group (CME) in Q4 2025, closing a stake of 4,017 shares — an estimated $1.09M sold.

Bailard first reported a position in CME in Q4 2018 and held it in 13 quarters. The position peaked at $1.16M in Q2 2025. 1,736 funds tracked by Wall St. Rank hold CME as of Q4 2025.

  • Bailard reported no remaining CME Group position as of Q4 2025 after selling out during the quarter.
  • Bailard sold 4,017 CME Group shares in Q4 2025, an estimated $1.09M.
  • Bailard first reported a position in CME Group in Q4 2018 and held it in 13 quarters.
  • Bailard's CME Group position peaked at $1.16M in Q2 2025.
  • 1,736 funds tracked by Wall St. Rank held CME Group as of Q4 2025.

Based on Bailard's 13F filing for Q4 2025, filed 4 Feb 2026.